Aug. 30, 2025, 10 a.m.| Sr no | Type | Resolution | IiAS View |
|---|---|---|---|
| 1 | Special | Approve scheme of arrangement for of Viyash Life Sciences Private Limited (Viyash) and its various subsidiaries, including Symed Labs Limited, Appcure Labs Pvt Ltd, Vindhya Pharma (India) Private Limited, Vandana Life Sciences Private Limited, SV Labs Private Limited, Geninn Life Sciences Private Limited and Vindhya Organics Private Limited along with Sequent Research Ltd (a wholly owned subsidiary of Sequent Scientific Limited (Sequent), with Sequent being the ultimate surviving entity |  |